Table 1 Baseline characteristics
Variables | Group LN (n = 385) | Group OVW (n = 501) | Group OBS (n = 120) | P | P1 | P2 | P3 |
|---|---|---|---|---|---|---|---|
Age | 63.8 (8.2) | 61.2 (9.1) | 59.3 (9.7) | < 0.001* | < 0.001* | < 0.001* | 0.008* |
Male | 189 (68.2) | 392 (81.7) | 199 (79.9) | < 0.001* | < 0.001* | 0.003* | 0.618 |
Risk factors | |||||||
Smoking | 117 (42.2) | 263 (54.8) | 127 (51.0) | 0.004* | 0.001* | 0.054 | 0.348 |
Drinking | 111 (40.1) | 246 (51.2) | 121 (48.6) | 0.011* | 0.002* | 0.052 | 0.532 |
Chronic obstructive pulmonary disease | 4 (1.4) | 6 (1.3) | 1 (0.4) | 0.532 | - | - | - |
Hypertension | 185 (66.8) | 311 (64.8) | 180 (72.3) | 0.121 | - | - | - |
Diabetes mellitus | 110 (39.7) | 197 (41.0) | 92 (36.9) | 0.565 | - | - | - |
Dyslipidemia | 230 (83.0) | 392 (81.7) | 215 (86.3) | 0.284 | - | - | - |
Atrial fibrillation | 11 (4.0) | 14 (2.9) | 8 (3.2) | 0.784 | - | - | - |
Myocardial infarction | 81 (29.2) | 193 (40.2) | 96 (38.6) | 0.009* | 0.002* | 0.027* | 0.09 |
Percutaneous coronary intervention | 23(8.3) | 44(9.2) | 17 (6.8) | 0.553 | - | - | - |
Pulmonary hypertension | 3(1.1) | 7 (1.5) | 3 (1.2) | 0.937 | - | - | - |
Peripheral vascular diseases | 39 (14.1) | 79 (16.5) | 36 (14.5) | 0.628 | - | - | - |
Neurological events | 30 (10.8) | 37 (7.7) | 13 (5.2) | 0.056 | - | - | - |
LVEF | 59.0 (7.6) | 58.8 (6.9) | 59.6 (7.0) | 0.364 | - | - | - |
Creatinine (mmol/L) | 85.0 (22.7) | 87.6 (19.6) | 87.3 (20.6) | 0.239 | - | - | - |